Drug given in cardiogenic shock is:
**Question:** Drug given in cardiogenic shock is:
A. Nitroglycerin
B. Vasopressors
C. Diuretics
D. Beta-blockers
**Core Concept:** Cardiogenic shock is a clinical syndrome characterized by inadequate cardiac output to meet the body's requirements, typically due to myocardial infarction or other myocardial dysfunction.
**Why the Correct Answer is Right:**
B. Vasopressors (e.g., noradrenaline, adrenaline, or vasopressin) are often used in cardiogenic shock to increase cardiac output by raising systemic vascular resistance and improving preload and afterload. Vasopressors are not primarily used for their anti-ischemic properties, but to enhance cardiac function.
**Why Each Wrong Option is Incorrect:**
A. Nitroglycerin is primarily used to dilate blood vessels to improve coronary blood flow, not to increase systemic vascular resistance or cardiac output in cardiogenic shock.
C. Diuretics (e.g., furosemide) are used to reduce preload by increasing renal blood flow and urine output, which helps reduce congestive heart failure. However, they are not typically used in cardiogenic shock to directly improve cardiac output.
D. Beta-blockers (e.g., metoprolol or propranolol) are used to reduce heart rate and myocardial contractility, which is helpful in certain conditions like post-infarction angina or arrhythmias. However, they are not primarily indicated for improving cardiac output in cardiogenic shock.
**Core Anatomy and Physiology:**
Cardiogenic shock results from inadequate cardiac output due to decreased contractility or increased afterload, which leads to decreased perfusion to vital organs and systems. As a result, vasopressors help increase cardiac output and improve perfusion, while nitroglycerin, diuretics, and beta-blockers are not the primary treatment options for this condition.
**Clinical Pearl:** In cardiogenic shock, the choice of therapy depends on the underlying cause, hemodynamic status, and patient response. Consulting a cardiologist and closely monitoring the patient's hemodynamics and response to therapy are crucial for appropriate management.